2nd Quarter - Amendment

IPOLICY SOLUTIONS for ASSOCIATION FOR MOLECULAR PATHOLOGY

Firm
Client
Income
$63,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 19, 2022 $63,000 Replaced
2nd Quarter - Amendment (this page) May 15, 2023 $63,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act S.4348 - FDASLA Act of 2022

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor, and Pensions
JAY QIU —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 4348 (117th), H.R. 4128 (117th)

Copyright/Patent/Trademark CPT

U.S. Patent Act Sec. 101 Reforms

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Legislative Fellow, Committee on Health, Education, Labor, and Pensions
JAY QIU —

Contacted: SENATE

Health Issues HCR

S.3799, PREVENT Pandemics Act Pandemic response and supply chain issues

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Health, Education, Labor and Pensions
JAY QIU —

Contacted: SENATE; Office of Science & Technology Policy (OSTP)

Bills named: S. 3799 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.